This single-center, randomized clinical trial followed 161 patients who met National Cholesterol Education Program (NCEP) II criteria for lipid-lowering therapy.

• 此次单中心随机临床试验对161位符合美国胆固醇教育方案第II级降血脂治疗的患者随访。